CTOR

CITIUS ONCOLOGY, INC. CTOR

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$1.49M

Quarter to Jun 30

Net income

$-8.92M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$9.20M total
ARMISTICE CAPITAL, LLC
$5.66M-5.3%
BANK OF AMERICA CORP /DE/
$2.49M0.0%
VANGUARD CAPITAL MANAGEMENT LLC
$355.1K+2.2%
UBS Group AG
$217.5K+808.3%
GEODE CAPITAL MANAGEMENT, LLC
$159.5K-7.3%
VANGUARD FIDUCIARY TRUST CO
$79.2K0.0%
IFP Advisors, Inc
$69.8K0.0%
CITADEL ADVISORS LLC
$58.9KNew
NORTHERN TRUST CORP
$29.7K0.0%
STATE STREET CORP
$27.9K0.0%
Virtu Financial LLC
$14.0KNew
XTX Topco Ltd
$13.4KNew
Tower Research Capital LLC (TRC)
$9.0KNew
Arkadios Wealth Advisors
$7.6K0.0%
OSAIC HOLDINGS, INC.
$650-90.1%
WELLS FARGO & COMPANY/MN
$325New
BARCLAYS PLC
$59New
MORGAN STANLEY
$15New
Caitong International Asset Management Co., Ltd
$10.0%
See all 19 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q3 2026
EDGAR

Net Income

Q3 2026
EDGAR

EPS (Diluted)

Q3 2026
EDGAR

ROIC

Q3 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CTOR

Earnings Per Share

13fpro.ai/company/CTOR

Loading ratio trend…

About CITIUS ONCOLOGY, INC. (CTOR): stock profile, AI score and financials

CITIUS ONCOLOGY, INC. (CTOR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CTOR is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q3 2026), CITIUS ONCOLOGY, INC. reports quarterly revenue of $1.5M, net income of $-8.9M. Top institutional holders of CTOR by reported 13-F value include ARMISTICE CAPITAL, BANK OF AMERICA, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. CTOR trades on the Nasdaq exchange and files with the SEC under CIK 1851484. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CTOR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CITIUS ONCOLOGY, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1851484 →